Answers are grounded in this paper and cite their sources.
Scar formation after hand surgery poses unique functional and aesthetic challenges because of the hand's complex anatomy, dense sensory innervation, and reliance on supple skin and tendon glide. Hypertrophic scars, keloids, adherent scars, and contractures can cause pain, hypersensitivity, restricted motion, and impaired activities of daily living, yet evidence guiding scar management in hand surgery remains limited and largely extrapolated from burn and general surgical populations. This review synthesizes current evidence on the biology, classification, prevention, and treatment of scars as they pertain to hand surgery. Nonoperative management, including silicone gel sheeting, compression therapy, intralesional corticosteroid injection, laser therapy, and hand therapy, forms the foundation of care. Operative interventions, ranging from scar excision and Z-plasty to skin grafting, local flap reconstruction, dermal substitutes, and tenolysis, address established contracture and adhesion when conservative measures fail. Emerging therapies, such as autologous fat grafting, growth factor modulation, platelet-rich plasma, and botulinum toxin A, show early promise but require validation in hand-specific trials. Optimal outcomes depend on a collaborative, individualized approach integrating patient risk stratification, meticulous surgical technique, and close coordination with hand therapy throughout the care continuum.
No takes yet. Share an insight, caveat, or question.
Chi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: